Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine whether febuxostat and benzbromarone could protect renal function, and which one could be better.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Shanghai 10th People's Hospital
NCT07187830 · Chronic Kidney Disease in Type 2 Diabetes, Obesity & Overweight
NCT07105670 · Chronic Kidney Disease Stage 3
NCT05398783 · Metabolic Disorders, Cancer, and more
NCT07547098 · Cardiovascular Diseases (CVD), Chronic Kidney Disease, and more
NCT07232537 · Chronic Kidney Disease, Type 2 Diabetes Mellitus
Department of Nephrology & Rheumatology, Shanghai Tenth People's Hospital
Shanghai, Shanghai Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions